ACAAI 2018: Safety of Oral Peanut Immunotherapy Observed in Open-Label Extension Trial
Long-term treatment with a peanut oral immunotherapeutic maintained desensitization and was well-tolerated
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.